相似文献
1
Eicosanoids and cancer.
Nat Rev Cancer. 2010 Mar;10(3):181-93. doi: 10.1038/nrc2809. Epub 2010 Feb 19.
2
Thrombospondin-1 interactions regulate eicosanoid metabolism and signaling in cancer-related inflammation.
Cancer Metastasis Rev. 2018 Sep;37(2-3):469-476. doi: 10.1007/s10555-018-9737-x.
3
Immunoregulatory mechanisms of the arachidonic acid pathway in cancer.
FEBS Lett. 2025 Apr;599(7):927-951. doi: 10.1002/1873-3468.70013. Epub 2025 Feb 20.
4
Eicosanoids and HB-EGF/EGFR in cancer.
Cancer Metastasis Rev. 2018 Sep;37(2-3):385-395. doi: 10.1007/s10555-018-9746-9.
5
Regulation of inflammation in cancer by dietary eicosanoids.
Pharmacol Ther. 2023 Aug;248:108455. doi: 10.1016/j.pharmthera.2023.108455. Epub 2023 May 29.
6
Tumor microenvironment: the role of the tumor stroma in cancer.
J Cell Biochem. 2007 Jul 1;101(4):805-15. doi: 10.1002/jcb.21159.
7
Regulation of inflammation in cancer by eicosanoids.
Prostaglandins Other Lipid Mediat. 2011 Nov;96(1-4):27-36. doi: 10.1016/j.prostaglandins.2011.08.004. Epub 2011 Aug 16.
8
Triumph and tumult of matrix metalloproteinases and their crosstalk with eicosanoids in cancer.
Cancer Metastasis Rev. 2018 Sep;37(2-3):279-288. doi: 10.1007/s10555-018-9756-7.
9
Eicosanoid profiling in an orthotopic model of lung cancer progression by mass spectrometry demonstrates selective production of leukotrienes by inflammatory cells of the microenvironment.
PLoS One. 2013 Nov 11;8(11):e79633. doi: 10.1371/journal.pone.0079633. eCollection 2013.
10
Eicosanoids and cancer.
Clinics (Sao Paulo). 2018 Aug 20;73(suppl 1):e530s. doi: 10.6061/clinics/2018/e530s.
引用本文的文献
1
3D Genome Engineering: Current Advances and Therapeutic Opportunities in Human Diseases.
Research (Wash D C). 2025 Sep 1;8:0865. doi: 10.34133/research.0865. eCollection 2025.
2
Immunosuppressants/Immunomodulators and Malignancy.
J Clin Med. 2025 Jul 21;14(14):5160. doi: 10.3390/jcm14145160.
3
ACACA depletion activates the cPLA2-arachidonic acid-NF-κB axis to drive inflammatory reprogramming in androgen receptor-independent prostate cancer.
Cell Commun Signal. 2025 Jul 25;23(1):352. doi: 10.1186/s12964-025-02363-0.
4
The advances of DNA methylation in the liquid biopsy for the detection of lung cancer.
Front Oncol. 2025 Jul 1;15:1547797. doi: 10.3389/fonc.2025.1547797. eCollection 2025.
5
Metabolites as agents and targets for cancer immunotherapy.
Nat Rev Drug Discov. 2025 Jun 26. doi: 10.1038/s41573-025-01227-z.
6
Targeting Biomarkers of Proliferation and Inflammation (Ki67, p53, and COX-2) in Actinic Keratoses with Photodynamic Therapy.
Biomedicines. 2025 Jun 17;13(6):1487. doi: 10.3390/biomedicines13061487.
7
Hypoxanthine activates PI3K/AKT pathway and lipid metabolism, hallmarks in breast cancer metastasis.
Med Oncol. 2025 Jun 16;42(7):263. doi: 10.1007/s12032-025-02829-8.
8
Eflornithine for the Chemoprevention of Luminal Gastrointestinal Neoplasms: A Systematic Review.
Gastroenterology Res. 2025 Jun;18(3):93-100. doi: 10.14740/gr1801. Epub 2025 Jun 4.
9
Modulation of lipid metabolism by exercise: exploring its potential as a therapeutic target in cancer endocrinology.
Front Endocrinol (Lausanne). 2025 May 23;16:1580559. doi: 10.3389/fendo.2025.1580559. eCollection 2025.
10
Tumor hypoxia shapes natural killer cell anticancer activities.
J Mol Med (Berl). 2025 May 30. doi: 10.1007/s00109-025-02557-6.
本文引用的文献
1
The role of KRAS mutation testing in the management of patients with metastatic colorectal cancer.
Arch Pathol Lab Med. 2009 Oct;133(10):1600-6. doi: 10.5858/133.10.1600.
2
Aspirin use and survival after diagnosis of colorectal cancer.
JAMA. 2009 Aug 12;302(6):649-58. doi: 10.1001/jama.2009.1112.
3
15-hydroxyprostaglandin dehydrogenase is down-regulated in gastric cancer.
Clin Cancer Res. 2009 Jul 15;15(14):4572-80. doi: 10.1158/1078-0432.CCR-08-2518. Epub 2009 Jul 7.
4
Prostaglandin F2alpha-F-prostanoid receptor signaling promotes neutrophil chemotaxis via chemokine (C-X-C motif) ligand 1 in endometrial adenocarcinoma.
Cancer Res. 2009 Jul 15;69(14):5726-33. doi: 10.1158/0008-5472.CAN-09-0390. Epub 2009 Jun 23.
5
[6]-Gingerol suppresses colon cancer growth by targeting leukotriene A4 hydrolase.
Cancer Res. 2009 Jul 1;69(13):5584-91. doi: 10.1158/0008-5472.CAN-09-0491. Epub 2009 Jun 16.
6
15-Hydroxyprostaglandin dehydrogenase inactivation as a mechanism of resistance to celecoxib chemoprevention of colon tumors.
Proc Natl Acad Sci U S A. 2009 Jun 9;106(23):9409-13. doi: 10.1073/pnas.0902367106. Epub 2009 May 22.
7
Prostaglandin E2-EP4 signaling promotes immune inflammation through Th1 cell differentiation and Th17 cell expansion.
Nat Med. 2009 Jun;15(6):633-40. doi: 10.1038/nm.1968.
8
The CysLT1 ligand leukotriene D4 supports alpha4beta1- and alpha5beta1-mediated adhesion and proliferation of CD34+ hematopoietic progenitor cells.
J Immunol. 2009 Jun 1;182(11):6789-98. doi: 10.4049/jimmunol.0801525.
9
Transcellular biosynthesis of cysteinyl leukotrienes in vivo during mouse peritoneal inflammation.
Proc Natl Acad Sci U S A. 2009 May 19;106(20):8296-301. doi: 10.1073/pnas.0903851106. Epub 2009 May 4.
10
Aspirin and non-steroidal anti-inflammatory drugs for cancer prevention: an international consensus statement.
Lancet Oncol. 2009 May;10(5):501-7. doi: 10.1016/S1470-2045(09)70035-X.
Zotero 插件